ClinicalTrials.Veeva

Menu

Clinico-immunological Characterization and Immune Tolerance Breakdown in HU-autoimmunity (CarTo-Hu)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Active, not recruiting

Conditions

Immune Tolerance

Treatments

Other: Description of clinical, immunological and tumor features of patients harboring Hu Abs

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Phenotypic characterization of patients with Hu-Abs, including the different neurological presentation and the presence or not of an underlying cancer.

Analysis and clinical correlation of the diagnostic techniques for Hu-Abs detection (immunofluorescence, immunodot/Western blot, and CBA) in serum and/or CSF.

Genomic and transcriptomic features of tumors (histological and immune infiltrate characteristics, transcriptomic profile, mutational status).

Enrollment

400 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

  • Inclusion Criteria * :

    • Patient with neurological disorder
    • Patient with Hu antibody in sera or CSF
  • Exclusion Criteria * :

    • Patient with no data
    • Patient without neurological disorder
    • Patient without Hu antibody in sera/CSF

Trial design

400 participants in 1 patient group

Patients with Hu Abs
Description:
Patients harboring Hu Abs and a neurological syndrome
Treatment:
Other: Description of clinical, immunological and tumor features of patients harboring Hu Abs

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems